Ken Nelson

Ken Nelson Email and Phone Number

Partner and Co-Founder @ MedTech Advantage Fund
Dallas, TX, US
Ken Nelson's Location
Dallas, Texas, United States, United States
Ken Nelson's Contact Details
About Ken Nelson

Over the past 10 years, I have led commercial efforts for disruptive technologies in the digital health, wearables, and cardiac remote patient monitoring industries, playing a significant role in building the teams and cultures for 3 of the top 4 market share players, including #1 (BioTelemetry), #2 (iRhythm), and #4 (Bardy Diagnostics). Overall, I’m a 20 year digital health, medical device, and remote monitoring innovator with successful senior leadership experience ranging from a Fortune 500 company (Boston Scientific) to a medium sized #1 market share (Biotelemetry, acquisition by Philips for $2.8 Billion in December '20) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which was acquired by HillRom (Bardy Diagnostics) in August '21 for what will end up being $400M+ after milestone payments.Along the way I accomplished the following achievements most recently:• Built the teams, culture, and infrastructure, as well as developed the strategies and executed on the business plans to help drive global commercialization efforts of a disruptive cardiac monitoring patch (CAM Patch), resulting in multiple rounds of venture capital, including a $35M+ round in April 2019.• Raised significant shareholder value as well as a combined $100M+ in venture capital funding for iRhythm and Bardy Diagnostics, leading successful commercialization efforts for both by focusing on recruiting the right people, building the right culture, and developing strategic plans that led to explosive growth. • Led Biotelemetry to profitability for the first time ever, and grew them to the #1 market share player, in part by developing a winning team and culture to successfully grow revenue for 18 consecutive quarters from $111M in revenue in 2012 to $208M in revenue in 2016, exceeding quota in all 18 quarters. • Drove successful acquisitions of competitors and emerging technology, as well as developed impactful strategic partnerships, all of which added to the explosive growth of these companies. Specialties: Sales and marketing leadership and management, building winning teams and cultures, commercialization and scaling of start-ups, venture capital fundraising, business planning, medical device sales, disruptive new product launches, Cardiology and Electrophysiology implantables and diagnostics, National Accounts, market development, marketing, recruiting and hiring sales talent, people development, contracting (negotiating and deal structuring), finance, strategic operations, strategic pricing, budgeting, and forecasting. Exit

Ken Nelson's Current Company Details
MedTech Advantage Fund

Medtech Advantage Fund

View
Partner and Co-Founder
Dallas, TX, US
Ken Nelson Work Experience Details
  • Medtech Advantage Fund
    Partner And Co-Founder
    Medtech Advantage Fund
    Dallas, Tx, Us
  • Heart Rhythm Society
    Heart Rhythm Society (Hrs) Innovation Advisory Board & Task Force
    Heart Rhythm Society Jun 2024 - Present
    Washington, Dc, Us
    * Driving innovation is a key tenant of the Heart Rhythm Society’s (HRS) strategic plan. As home to leaders in the field of heart rhythm care, HRS is uniquely positioned to serve as a conduit for individuals unified in the pursuit of advanced solutions in the care of patients.* HRS recognizes that to drive innovation, new approaches are necessary. HRS launched HRX in September 2022 initially focused on cardiovascular digital health. Over the last couple of years, HRX has become an incubator for cardiovascular innovation for those who are keen on learning about cutting-edge breakthroughs and opportunities, exchanging insights, and engaging in meaningful discussions that excite their intellect and awaken their curiosity.* Continuing to build on the stepping stone laid by HRX, the Innovation Panel will provide strategy and direction on the HRS Strategic Plan pillar to Drive Innovation
    View
  • Epitel
    Board Of Directors
    Epitel Jun 2024 - Present
    Salt Lake City, Ut, Us
    * Epitel is a digital health company modernizing brain health solutions to improve seizure monitoring and detection. By leveraging our proprietary cloud-based wearable sensor system and other innovative AI technologies, we are empowering better treatment decisions by making EEG readily deployable and accessible. We are headquartered in Salt Lake City.* Epitel has developed a wearable, wireless EEG monitoring platform to provide accessible, affordable, and reliable electrographic seizure detection. Epitel received FDA clearance for its first product, known as REMI™ Remote EEG Monitoring System, in 2021.
    View
  • Acarix
    Board Of Directors
    Acarix May 2024 - Present
    Malmö, Skane County, Se
    Acarix (Ticker = ACIXF (OTCMKTS)) * Acarix’s (www.acarix.com) CADScor®System is an AI-powered acoustic diagnostic aid to rule out coronary artery disease in 10 minutes!* Acarix's CADScor®System is used to rule-out significant CAD in patients experiencing chest pain or shortness of breath* www.acarix.com
    View
  • Heartbeam Inc. (Nasdaq: Beat)
    Board Of Directors
    Heartbeam Inc. (Nasdaq: Beat) Jun 2023 - Present
    Santa Clara , Ca, Us
    About HeartBeam, Inc. - HeartBeam, Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform intended for patient use at home. By applying a suite of proprietary algorithms to simplify vector electrocardiography (VECG), the HeartBeam platform enables patients and their clinicians to assess their cardiac symptoms quickly and easily, so care can be expedited, if required. HeartBeam has two patented products in development. HeartBeam AIMI™ is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack. HeartBeam AIMIGo™ is the first and only credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms. HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies. For more information, visit www.HeartBeam.com.
    View
  • Cardiacare
    Chairman, Board Of Directors
    Cardiacare Jan 2023 - Present
    Ness Tsiona , Israel, Il
    CardiaCare has developed a wearable therapy for atrial fibrillation (currently in clinical study stage). CardiaCare's technology utilizes noninvasive peripheral neuromodulation to mediate a cardiovascular anti-arrhythmic response that reduces atrial fibrillation burden. The technology employs a closed-loop approach, involving monitoring and therapy. The wearable wrist-band combines advanced ECG and PPG sensors with AI-based treatment algorithms to induce a neuromodulation stimulus.CardiaCare's neuromodulation of the median and ulnar nerves balances sympathetic (stellate) and parasympathetic (vagus) tone via the brachial plexus. This induces a cardiovascular anti-arrhythmic response, reduces premature atrial contractions, modulates heart rate and rhythm, and reduces atrial fibrillation triggers and burden.CardiaCare is based on multiple clinical observations with neuromodulation therapy in patients with atrial fibrillation. CardiaCare has completed a technical and clinical proof of concept and secured its intellectual property. In addition, CardiaCare is a MedTech Innovator (www.medtechinnovator.org) startup accelerator alumni company as part of the 2022 cohort of companies. MedTech Innovator is the largest MedTech and Digital Health startup accelerator in the world.www.my-cardiacare.com
    View
  • Medtech Advantage Fund
    Partner
    Medtech Advantage Fund Jan 2023 - Present
    Medical Device and Digital Health focused Venture Capital Fund focused on MedTech Innovator alumni companies. MedTech Innovator is the largest MedTech and Digital Health startup accelerator globally (per PitchBook). www.medtechinnovator.org
  • Happitech
    Board Of Directors
    Happitech Jan 2023 - Present
    Amsterdam, North Holland, Nl
    Happitech (www.happitech.com) is disrupting the cardiac digital health and remote patient monitoring space by providing a arrhythmia detection option to anyone globally with a smart phone via PPG in the smart phone camera, without the need for any additional hardware. In other words, Happitech provides personalized heart health monitoring anywhere, anytime right from the smart phone in your pocket.
    View
  • American Heart Association
    Aha Health Technology Innovation Business Advisory Board
    American Heart Association Jan 2023 - Present
    Dallas, Texas, Us
    * The American Heart Association (AHA)’s Center for Health Tech Innovation (CHTI)'s Health Technology Innovation Business Advisory Group closely collaborates with advisory groups that help develop innovative and emerging solutions and strategies to improve healthcare outcomes in heart and brain health.* The Health Tech Advisory Group advises and guides the American Heart Association by offering insights into industry trends, connecting the AHA with experts and recommending valuable connections. They provide direction on research and engagement models and spearhead the development of health tech events, tools, and resources.
    View
  • Biotronik
    Head Of Digital Health, Diagnostics, & Monitoring
    Biotronik Nov 2020 - Jan 2023
    Berlin, De
    View
  • Bardy Diagnostics, Inc.
    Chief Commercial Officer
    Bardy Diagnostics, Inc. Sep 2017 - Aug 2020
    Deerfield, Illinois, Us
    Acquired by HillRom in August '21 (then HillRom acquired by Baxter in December '21)* Chief Commercial Officer * SVP, Corporate Development (Sept. '17 - Apr. '18) - Responsible for building and leading Bardy Diagnostics' Global Sales, Marketing, Business Development, International Market Development, Customer Experience, Clinical Services Teams, Payor Relations, & EHR Integration Teams - Built the teams, culture, and infrastructure, as well as developed the strategies and executed on business plans to help drive global commercialization efforts of a disruptive cardiac monitoring patch (CAM Patch), resulting in the following:o Drove monthly patient volumes from 775 patients to 10,000+ patients in my first 2 years.o Built customers from a small handful to over 500 accounts and 1,500+ physician prescribers.o Executed on strategic plans resulting in 10 consecutive quarters above global quotas. - Recruited and developed a commercial team of just under 100 people, half of which included 5 Regional Sales Directors and 45 Sales Reps across the U.S. and Distributors in Europe and Canada. - Drove fundraising efforts, along with our CEO, raising over $50M in VC funding, inclusive of a $35.5M Series B venture capital round in April ’19. - Pitched and won the opportunity to participate in 2 top ranked healthcare start-up accelerator programs: MedTech Innovator (largest MedTech startup accelerator in the world, BardyDx was a "Showcase" company in their 2019 cohort) and HealthTech Arkansas (1 of 5 companies selected for cohort). - Won the following Digital Health and Medical Device Innovation pitch competitions on behalf of BardyDx: European Society of Cardiology’s Remote Monitoring in Arrhythmias Digital Health Pitch Session (2019), MedTech Innovator & Wilson Sonsini Showcase Program (2019), SXSW’s Impact Pediatric Health Pitch Competition & $25,000 Grant (2019), and Children’s National Pediatric Cardiology Device Innovation Pitch Competition & $25,000 Grant (2018).
    View
  • Biotelemetry Healthcare, Formerly Cardionet/Mednet
    Vice President Of Sales, U.S.
    Biotelemetry Healthcare, Formerly Cardionet/Mednet Mar 2012 - Mar 2017
    Malvern, Pa, Us
    Acquired by Philips* Vice President of Sales, U.S. (promoted January 2013) * Director of Business Development, Worldwide (Started March 2012)* Hired, developed and motivated a team to successfully grow business for the past 19 consecutive quarters to a $160 Million+ annual run rate, with 14.8% growth in 2016 over 2015* Played a significant role in helping to drive the stock price from $2 per share to $30+ per share over past 5 years by leading business development and sales strategies, and recruiting, developing, and retaining sales team of 8 Regional Sales Directors and 100 Sales Reps with 18 consecutive quarters of growth.* Reduced sales team turnover to 4.6% by focusing on people development after taking over a team in need of a turnaround with 3 consecutive years of 40%+ turnover of the sales team and declining sales* Exceeded or met quarterly corporate sales targets for U.S. every quarter I have led the sales team, growing annual patients from 229,000 to 600,000+ through a combination of organic growth and acquisitions.* Initiated and successfully negotiated a multi-year research and development agreement and strategic partnership with the Belgium based nano-electronics research center IMEC, along with Denmark based DELTA to co-develop multiple revolutionary mHealth and cardiac monitoring patch products, eventually leading to the acquisition of DELTA’s ePatch division in April ’16.* Researched and initiated the acquisition of the cardiac monitoring division of Biomedical Systems in April ’14, and successfully integrated their national sales team into Cardionet’s sales team.* Experience leading both domestic and international merger, acquisition, and business development activity, as well as mHealth and cardiac device industry strategic partnership activity for market share leading public cardiac digital health and remote patient monitoring company. * Active participant in quarterly Board of Director meetings with a public company structure.
    View
  • Irhythm Technologies, Inc.
    Vice President Of Sales, Marketing, & Market Development
    Irhythm Technologies, Inc. Jun 2010 - Dec 2011
    San Francisco, Ca, Us
    * Vice President of Sales (U.S.), Marketing, Market Development & Training (promoted January 2011)* National Director of Sales, U.S. (Started June 2010) Recruited by senior leadership at St. Jude Medical (now Abbott), which had just made an investment in iRhythm at that time, to lead all commercial efforts at iRhythm and help build a strategic partnership and co-marketing agreement with the St. Jude Medical Cardiac Rhythm Management (CRM) Division. Drove significant sales growth each quarter, leading to roughly $50M in venture capital including an additional investment from St. Jude Medical in May ’11, an investment round led by Kaiser Permanente Ventures in October 2011, and then eventually an extremely successful IPO (Ticker = IRTC). Grew revolutionary new cardiac monitoring device sales from less than 2,500 devices in 2010 to over 30,000 devices in 2011. Built a national sales team of 6 Regional Sales Managers and 16 Territory Managers from a team of 7, taking iRhythm from a small struggling start-up medical device and diagnostics company to a fast growing, disruptive digital health and remote patient monitoring company Interviewed over 200 candidates and hired 17 sales people within my first 9 months.  As a member of iRhythm’s Executive Team, I was an active participant at all Board meetings. Led and developed strategies and business plans for the sales, marketing, market development, and training teams.
    View
  • Boston Scientific
    Regional Sales Manager
    Boston Scientific Jul 2002 - Dec 2009
    Marlborough, Ma, Us
    * Regional Sales Manager, Cardiac Rhythm Management (Promoted December '07)* Area Business Manager (Promoted December '05)* Field Clinical Sales Representative (Promoted December '04)* National Accounts, Senior Associate (Promoted December '03)* Senior Sales & Pricing Analyst (Started July '02) Rebuilt the West TX-NM Region, hiring 9 sales people within my first 18 months as Regional Manager Led, managed, and developed a sales team of 15 reps and helped Region sales grow over 16% in 2009 Broke into the Albuquerque, NM; Roswell, NM; San Angelo, TX; and Brownwood, TX markets where BSC CRM historically had little to no revenue Grew the Region to roughly $16 Million+ in Annual Sales, while managing a contribution margin over 57% Took significant market share from competitors in 4 out of the 5 major cities in the West TX - NM Region Advised Area Sales VP on a daily basis regarding strategic sales operations of a $120 Million Sales Area Built relationships and collaborated with Area Sales VP and 7 Regional Sales Managers to drive execution on strategic corporate objectives and to improve the efficiency of critical business processes Excelled in and completed a selective 12 month Management Readiness Assessment (MRA) program, which is the management development program at Boston Scientific  Won Southwest Area Key Contributor Award as an ABM in 2007 and national ABM of the quarter in Q3 2007 Consulted directly with physicians on clinical issues during the implant of cardiac pacemakers and defibrillators as well as during post implant patient follow-ups across Dallas and Fort Worth Developed sales and pricing strategies and structured contracts for target Group Purchasing Organizations (GPOs) and Integrated Delivery Networks (IDNs), as well as large hospitals for Guidant National Accounts Won Guidant Sales Corp. (GSC) “SPOT” Awards in March ’06, April ’06, September ’06, and February ’07.
    View
  • Reachview Technologies
    Manager Of Strategic Operations
    Reachview Technologies Jun 2001 - Jul 2002
    Us
    * Recruited by VP of Sales and VP of Strategic Accounts at Verso Technologies to help start this company* Key contributor in all of the sales and financial related aspects of a start-up software company* Consulted with the CEO, COO, and VP of Sales to help establish finance, sales, and marketing strategies* Collaborated directly with the CEO to write the business plan, marketing collateral, and website content* Created budgets, forecasts, reports, and projects and consulted with management on strategic daily operations
    View
  • Verso Technologies
    Revenue Manager
    Verso Technologies Mar 2000 - Jun 2001
    Us
     Worked directly for the COO, VP of Sales, and Controller as a trusted advisor on sales and finance operations Presented sales analysis and forecast results weekly to the CEO, COO, and CFO in weekly executive meetings Managed Revenue Analyst team and oversaw revenue operations and the resolution of revenue related issues Received Finance/Accounting “Employee of the Year Award” for 2000 among a group of 25 employees
    View
  • Time Warner (Turner Network Sales)
    Financial Analyst
    Time Warner (Turner Network Sales) Aug 1999 - Mar 2000
    Atlanta, Georgia, Us
    Managed the financial relationships between Turner Network Sales (CNN, TBS, TNT, Headline News, CNN Sports Illustrated, CNN International, and Cartoon Network) and some of its major cable operator accounts
    View
  • Allstate Insurance Company
    Financial Analyst
    Allstate Insurance Company Aug 1997 - Aug 1999
    Northbrook, Il, Us
    View

Ken Nelson Skills

Market Development Medical Devices Strategy Sales Operations Competitive Analysis Sales Sales Management Product Launch Start Ups Cardiology Leadership Pricing Strategy Business Planning Budgets Crm Cross Functional Team Leadership Capital Equipment Forecasting Customer Relationship Management

Ken Nelson Education Details

  • Vanderbilt University
    Vanderbilt University
    And Spanish
  • Phillips Exeter Academy
    Phillips Exeter Academy

Frequently Asked Questions about Ken Nelson

What company does Ken Nelson work for?

Ken Nelson works for Medtech Advantage Fund

What is Ken Nelson's role at the current company?

Ken Nelson's current role is Partner and Co-Founder.

What is Ken Nelson's email address?

Ken Nelson's email address is ke****@****nik.com

What is Ken Nelson's direct phone number?

Ken Nelson's direct phone number is (800) 908*****

What schools did Ken Nelson attend?

Ken Nelson attended Vanderbilt University, Phillips Exeter Academy.

What skills is Ken Nelson known for?

Ken Nelson has skills like Market Development, Medical Devices, Strategy, Sales Operations, Competitive Analysis, Sales, Sales Management, Product Launch, Start Ups, Cardiology, Leadership, Pricing Strategy.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.